National Cancer Institute
Found 8477 results for your search:
Total relevant funding to Cancer for this search:
$5,636,393,224
Fiscal Year FY 2017
Research Topic [Cancer]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 8477 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
HHSN292201500060U $5,878,180 $5,878,180 N/A CONSTELLATION NEW ENERGY
2
(1 of 2) Florida Minority Cancer Research & Training Center: Feasibility Studies 5P20CA192990-04 $165,747 $165,747 REAMS, ROMONIA FLORIDA AGRICULTURAL AND MECHANICAL UNIV
3
(1) Intestinal Organoid Models for APC LOH 5R21CA208638-02 $192,406 $192,406 GIARDINA, CHARLES UNIVERSITY OF CONNECTICUT STORRS
4
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership 2U54CA163071-06 $1,427,230 $1,427,230 MATTA, JAIME PONCE SCHOOL OF MEDICINE
5
(1/2) University of Guam/University of Hawaii Cancer Center Partnership 5U54CA143727-08 $1,188,362 $1,188,362 PALAFOX, NEAL UNIVERSITY OF HAWAII AT MANOA
6
(10.) The Gut Microbiome and Responses to Neoadjuvant Chemoradiation in Rectal Cancer Patients 5R21CA205636-02 $202,275 $202,275 CHEN, GRACE UNIVERSITY OF MICHIGAN
7
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities 5U54CA143930-08 $704,474 $704,474 FARIAS-EISNER, ROBIN UNIVERSITY OF CALIFORNIA LOS ANGELES
8
(2/2) Howard University/Johns Hopkins Partnership in HPV-Related Cancer Research 5P20CA192988-04 $179,686 $179,686 WU, TZYY-CHOOU JOHNS HOPKINS UNIVERSITY
9
(6) Molecular mechanisms explaining premalignant changes in the etiology of melanoma 1R21CA208736-01A1 $146,000 $146,000 MURPH, MANDI UNIVERSITY OF GEORGIA
10
(7) Novel imaging devices for measurement and control of tumor microenvironments 1R01CA216248-01 $565,675 $565,675 CONDEELIS, JOHN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
11
(9) Biophysical Description of Age and Dose Dependent Changes to Dendritic Morphology that Impact Cognition following Radiation Cancer Therapy 5R01CA208526-02 $472,047 $472,047 CUCINOTTA, FRANCIS UNIVERSITY OF NEVADA LAS VEGAS
12
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics 1R01CA215802-01 $503,309 $503,309 SPARREBOOM, ALEXANDER OHIO STATE UNIVERSITY
13
(Diversity supplement to R01CA188096) Targeting autophagaphy in hereditary breast cancer 3R01CA188096-03S1 $57,707 $57,707 XIA, BING RBHS -CANCER INSTITUTE OF NEW JERSEY
14
(NSF: 2018 GENERAL SOCIAL SURV) ADDING GLOBAL HEALTH ITEMS TO THE 2018 GENERAL SOCIAL SURVEY APC17004 $187,328 $187,328 UNKNOWN, UNKNOWN NATIONAL SCIENCE FOUNDATION
15
(PQ #10) Gut-brain interactions underlying chemotherapy-induced behavioral comorbidities 1R01CA216290-01 $338,903 $338,903 PYTER, LEAH OHIO STATE UNIVERSITY
16
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblastoma 5R01CA190121-05 $362,088 $362,088 VERHAAK, ROELAND JACKSON LABORATORY
17
(PQ 5) Roles of mitochondrial heterogeneity in cell survival and oncogenesis 1R21CA216304-01 $234,900 $234,900 NEWMEYER, DONALD LA JOLLA INST FOR ALLERGY & IMMUNOLGY
18
(PQ 6) Exploiting Frequent Alterations in the PRC2 Complex to Distinguish Benign Neurofibromas from Malignant Peripheral Nerve Sheath Tumors 5R21CA208723-02 $177,852 $177,852 BETTEGOWDA, CHETAN JOHNS HOPKINS UNIVERSITY
19
(PQ 9) Dysregulation of epidermal MMP-13 as cause of paclitaxel-induced peripheral neuropathy 1R01CA215973-01 $443,022 $443,022 RIEGER, SANDRA MOUNT DESERT ISLAND BIOLOGICAL LAB
20
(PQ 9) Synaptic basis of deficits in attention and executive function following cranial radiation 5R01CA208535-02 $451,564 $451,564 GROSSHANS, DAVID UNIVERSITY OF TX MD ANDERSON CAN CTR
21
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration 1R01CA205965-01A1 $650,815 $650,815 CURIEL, TYLER UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
22
(PQ#9) Promoting Axon Stability to Prevent Therapy-induced Peripheral Neuropathy 1R01CA219866-01 $445,407 $445,407 DIANTONIO, AARON WASHINGTON UNIVERSITY
23
(PQ#9): Altered mitochondrial transport and chemotherapy-induced peripheral neuropathy 1R21CA215985-01 $198,000 $198,000 CHANG, KAREN UNIVERSITY OF SOUTHERN CALIFORNIA
24
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer. 5R01CA206025-02 $637,172 $637,172 GUISE, THERESA INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
25
(PQ1) Cellular senescence as an initiating event in malignant transformation 1R21CA206013-01A1 $203,400 $203,400 DAVID, GREGORY NEW YORK UNIVERSITY SCHOOL OF MEDICINE
26
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers 5R01CA205258-02 $464,261 $464,261 GUDAS, LORRAINE WEILL MEDICAL COLL OF CORNELL UNIV
27
(PQ1) Epigenetic effects of the premalignant field 5R01CA208620-02 $372,671 $372,671 TERADA, LANCE UT SOUTHWESTERN MEDICAL CENTER
28
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS) 5R01CA205954-02 $438,499 $438,499 GHOBRIAL, IRENE DANA-FARBER CANCER INST
29
(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation 5R01CA206026-02 $356,850 $356,850 WALDMAN, SCOTT THOMAS JEFFERSON UNIVERSITY
30
(PQ1) Identifying and targeting human glioblastoma migrating in the peritumoral niche 1R01CA216054-01 $324,411 $324,411 HAYDEN, MELANIE STANFORD UNIVERSITY
31
(PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer 1R01CA206483-01A1 $718,958 $718,958 EMU, BRINDA YALE UNIVERSITY
32
(PQ1) Molecular circuit of multi-ciliogenesis regulates choroid plexus differentiation and tumor development 1R01CA220551-01 $383,749 $383,749 ZHAO, HAOTIAN SANFORD RESEARCH/USD
33
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution 1R01CA219893-01 $442,614 $442,614 GHOSH, MOUMITA NATIONAL JEWISH HEALTH
34
(PQ1) Progression of the airway field of injury to Kras mutant lung cancer 5R01CA205608-02 $346,909 $346,909 SCHEET, PAUL UNIVERSITY OF TX MD ANDERSON CAN CTR
35
(PQ10) Do microbiota alter the epigenetic landscape in human genome 5R21CA208464-02 $212,063 $212,063 STRONGIN, ALEX SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
36
(PQ11) Reversing exosome-mediated immune suppression - a novel strategy for cancer therapy 5R21CA205644-02 $202,439 $202,439 WHITESIDE, THERESA UNIVERSITY OF PITTSBURGH AT PITTSBURGH
37
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer. 5R01CA208644-02 $377,438 $377,438 CRITTENDEN, MARKA PROVIDENCE PORTLAND MEDICAL CENTER
38
(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS 5R21CA206309-02 $182,192 $182,192 HARRIS, REUBEN UNIVERSITY OF MINNESOTA
39
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer 1R01CA219880-01 $697,539 $697,539 PALUCKA, ANNA KAROLINA JACKSON LABORATORY
40
(PQ3) Disruption of immune surveillance by aneuploidy and aberrant MHCII expression 1R01CA220009-01 $310,000 $310,000 ZANETTI, MAURIZIO UNIVERSITY OF CALIFORNIA SAN DIEGO
41
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection 5R01CA206476-02 $772,521 $772,521 CHIAO, ELIZABETH BAYLOR COLLEGE OF MEDICINE
42
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes 1R01CA216265-01 $632,860 $632,860 CHRISTENSEN, BROCK DARTMOUTH COLLEGE
43
(PQ3) Immune Modulation of DNA Mismatch Repair in Colorectal Cancer 5R01CA206010-02 $369,639 $369,639 CARETHERS, JOHN UNIVERSITY OF MICHIGAN
44
(PQ3) Modulation of Osteosarcoma Biology by Inflammation and Immunity Defined through a ComparativeApproach 5R21CA208529-02 $166,388 $166,388 MODIANO, JAIME UNIVERSITY OF MINNESOTA
45
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity 5R01CA208756-02 $518,165 $518,165 HACOHEN, NIR BROAD INSTITUTE, INC.
46
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years 5R01CA206477-02 $756,373 $756,373 PALEFSKY, JOEL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
47
(PQ4) Elucidating Determinants of Susceptibility to Tumorigenesis in the Skin 5R21CA208298-02 $180,459 $180,459 RAMSEY, MATTHEW BRIGHAM AND WOMEN'S HOSPITAL
48
(PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas 5R21CA208463-02 $174,000 $174,000 LOZANO, GUILLERMINA UNIVERSITY OF TX MD ANDERSON CAN CTR
49
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer 5R01CA206465-02 $527,068 $527,068 JUSTICE, AMY YALE UNIVERSITY
50
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression 3R01CA194461-03S1 $57,872 $57,872 PARK, KWON-SIK UNIVERSITY OF VIRGINIA
Total relevant funding to Cancer for this search: $5,636,393,224
Showing 1 - 50 of 8477 results
Go to top